Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award
Xuzhou Medical University, China
Author Profile
🎓Early Academic Pursuits
Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.
🌟Professional Endeavors
Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.
He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.
🔬Contributions and Research Focus
Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.
🏆Accolades and Recognition
Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.
🌏Impact and Influence
Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.
🌟Legacy and Future Contributions
Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.
🌟Final Thoughts
With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.
📖Notable Publications
Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
- Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
- Journal: Controlled Release
- Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
- Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
- Journal: Ginseng Research
- Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
- Authors : Xu, Y., Li, H., Sun, N., … Liu, S., Jiang, L.
- Journal: Pharmaceutical Sciences
- Year: 2023
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
- Authors : Zhang, M., Si, S.J., Dai, W.J., … Jin, F., Jiang, L.Q.
- Journal: Colloids and Surfaces B: Biointerfaces
- Year: 2023
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy
- Authors : Meng, J., Li, L., Xu, Y., … Zhou, X., Jiang, L.
- Journal: Colloids and Surfaces B: Biointerfaces
- Year: 2023